Research Papers:
NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 2893 views | HTML 2718 views | ?
Abstract
Li Qin1, Yan Xu2,3, Yixiang Xu1,4, Gang Ma1, Lan Liao1, Yelin Wu1,5, Yi Li6, Xian Wang6, Xiaosong Wang6, Jun Jiang3, Jin Wang7, Jianming Xu1,8
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA
2Department of Breast and Thyroid Surgery, Daping Hospital, Third Military Medical University, Chongqing, China
3Breast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, China
4Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX, USA
5Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China
6Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA
7Department of Pharmacology, Baylor College of Medicine, Houston, TX, USA
8Institute for Cancer Medicine and College of Basic Medical Sciences, Sichuan Medical University, Luzhou, Sichuan, China
Correspondence to:
Jianming Xu, e-mail: [email protected]
Li Qin, e-mail: [email protected]
Keywords: NCOA1, VEGFa, transcriptional regulation, breast cancer
Received: March 04, 2015 Accepted: June 09, 2015 Published: June 20, 2015
ABSTRACT
Nuclear receptor coactivator 1 (NCOA1) is overexpressed in a subset of breast cancer and its increased expression positively correlates with disease recurrence and metastasis. Although NCOA1 is known to promote breast cancer metastasis through working with multiple transcription factors to upregulate the expression of Twist1, ITGA5, CSF-1, SDF1 and CXCR4, the role of NCOA1 in breast tumor angiogenesis has not been investigated. In this study, we found that the microvascular density (MVD) was significantly decreased and increased in Ncoa1-knockout and NCOA1-overexpressing mammary tumors, respectively, in several breast cancer mouse models. Knockout or knockdown of NCOA1 in breast cancer cell lines also markedly compromised their capability to induce angiogenesis in Matrigel plugs embedded subcutaneously in mice, while this compromised capability could be rescued by VEGFa treatment. At the molecular level, NCOA1 upregulates VEGFa expression in both mouse mammary tumors and cultured breast cancer cells, and it does so by associating with both c-Fos, which is recruited to the AP-1 site at bp -938 of the VEGFa promoter, and HIF1α, which is recruited to the HIF1α-binding element at bp -979 of the VEGFa promoter, to enhance VEGFa transcription. In 140 human breast tumors, high NCOA1 protein correlates with high MVD and patients with both high NCOA1 and high MVD showed significantly shorter survival time. In summary, this study revealed a novel mechanism that NCOA1 potentiates breast cancer angiogenesis through upregulating HIF1α and AP-1-mediated VEGFa expression, which reinforces the rational of targeting NCOA1 in controlling breast cancer progression and metastasis.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 4341